Extensive protein-protein interactions involving UDPGLUCURONOSYLTRANSFERASe (UGT) 2B7 in human liver microsomes

Drug Metabolism and Pharmacokinetics

Volumn 29, Issue 3, 2014, Pages 259-265

  Fujiwara, Ryoichi ^a   Itoh, Tomoo ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

CYP3A4; Metabolosome; Protein protein interactions; UDP glucuronosyltransferase; UGT2B7

Indexed keywords

ADIPOCYTE PLASMA MEMBRANE ASSOCIATED PROTEIN; ALPHA ACTININ 4; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANION EXCHANGE PROTEIN 2; B CELL RECEPTOR ASSOCIATED PROTEIN 31; BETA TUBULIN; CYTOCHROME P450 1A2; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; ENDOPLASMIC RETICULUM RESIDENT PROTEIN 29; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 2B15; GLUCURONOSYLTRANSFERASE 2B7; GLUCURONOSYLTRANSFERASE 2B7 ANTIBODY; LONG CHAIN FATTY ACID COENZYME A LIGASE; MANNOSE OLIGOSACCHARIDE; MEMBRANE PROTEIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN LARGE SUBUNIT; MITOCHONDRIAL PYRUVATE CARRIER 2; N ACETYLGALACTOSAMINYLTRANSFERASE; NADH CYTOCHROME B5 REDUCTASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) TRANSHYDROGENASE; PEROXIREDOXIN 4; PEROXISOMAL MEMBRANE PROTEIN 2; PROHIBITIN; PROTEIN ANTIBODY; RETINOL BINDING PROTEIN 3; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1; ZINC FINGER PROTEIN PLAG1; GLUCURONOSYLTRANSFERASE; UGT2B7 PROTEIN, HUMAN;

ARTICLE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; ENZYMOLOGY; LIVER; METABOLISM; METABOLOME; PHYSIOLOGY; PROTEIN DOMAIN;

GLUCURONOSYLTRANSFERASE; HUMANS; IMMUNOPRECIPITATION; LIVER; METABOLOME; MICROSOMES, LIVER; PROTEIN INTERACTION DOMAINS AND MOTIFS;

EID: 84903577746     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-13-RG-096     Document Type: Article

References (29)

1. Dutton, G. J.: Acceptor substrates of UDP glucuronosyltransferase and their assay. In Dutton, G. J. (ed): Glucuronidation of Drugs and Other Compounds, Boca Raton, CRC Press, 1980, pp. 69-78.
2. Mackenzie, P. I., Bock, K. W., Burchell, B., Guillemette, C., Ikushiro, S., Iyanagi, T., Miners, J. O., Owens, I. S. and Nebert, D. W.: Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet. Genomics, 15: 677-685 (2005).
3. Ritter, J. K., Chen, F., Sheen, Y. Y., Tran, H. M., Kimura, S., Yeatman, M. T. and Owens, I. S.: A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J. Biol. Chem., 267: 3257-3261 (1992).
4. Tukey, R. H. and Strassburg, C. P.: Human UDP-glucuronosyltransferases: metabolism, expression and disease. Annu. Rev. Pharmacol. Toxicol., 40: 581-616 (2000).
5. Williams, J. A., Hyland, R., Jones, B. C., Smith, D. A., Hurst, S., Goosen, T. C., Peterkin, V., Koup, J. R. and Ball, S. E.: Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metab. Dispos., 32: 1201-1208 (2004).
6. Nakajima, M., Tanaka, E., Kobayashi, T., Ohashi, N., Kume, T. and Yokoi, T.: Imipramine N-glucuronidation in human liver microsomes: biphasic kinetics and characterization of UDP-glucuronosyltransferase isoforms. Drug Metab. Dispos., 30: 636-642 (2002).
7. Uchaipichat, V., Mackenzie, P. I., Elliot, D. J. and Miners, J. O.: Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases. Drug Metab. Dispos., 34: 449-456 (2006).
8. Shepherd, S. R., Baird, S. J., Hallinan, T. and Burchell, B.: An investigation of the transverse topology of bilirubin UDP- glucuronosyltransferase in rat hepatic endoplasmic reticulum. Biochem. J., 259: 617-620 (1989).
9. Csala, M., Staines, A. G., Bánhegyi, G., Mandl, J., Coughtrie, M. W. and Burchell, B.: Evidence for multiple glucuronide transporters in rat liver microsomes. Biochem. Pharmacol., 68: 1353-1362 (2004).
10. Muraoka, M., Kawakita, M. and Ishida, N.: Molecular characterization of human UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter, a novel nucleotide sugar transporter with dual substrate specificity. FEBS Lett., 495: 87-93 (2001).
11. Zheng, Y., Sun, D., Sharma, A. K., Chen, G., Amin, S. and Lazarus, P.: Elimination of antiestrogenic effects of active tamoxifen metabolites by glucuronidation. Drug Metab. Dispos., 35: 1942-1948 (2007).
12. Nakajima, M. and Yokoi, T.: Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation. Drug Metab. Pharmacokinet., 20: 227-235 (2005).
13. Ishii, Y., Iwanaga, M., Nishimura, Y., Takeda, S., Ikushiro, S., Nagata, K., Yamazoe, Y., Mackenzie, P. I. and Yamada, H.: Protein-protein interactions between rat hepatic cytochromes P450 (P450s) and UDPglucuronosyltransferases (UGTs): evidence for the functionally active UGT in P450-UGT complex. Drug Metab. Pharmacokinet., 22: 367-376 (2007).
14. Taura, K. I., Yamada, H., Hagino, Y., Ishii, Y., Mori, M. A. and Oguri, K.: Interaction between cytochrome P450 and other drug-metabolizing enzymes: evidence for an association of CYP1A1 with microsomal epoxide hydrolase and UDP-glucuronosyltransferase. Biochem. Biophys. Res. Commun., 273: 1048-1052 (2000).
15. Ikushiro, S., Sahara, M., Emi, Y., Yabusaki, Y. and Iyanagi, T.: Functional co-expression of xenobiotic metabolizing enzymes, rat cytochrome P450 1A1 and UDP-glucuronosyltransferase 1A6, in yeast microsomes. Biochim. Biophys. Acta, 1672: 86-92 (2004).
16. Finel, M. and Kurkela, M.: The UDP-glucuronosyltransferases as oligomeric enzymes. Curr. Drug Metab., 9: 70-76 (2008).
17. Fujiwara, R., Nakajima, M., Oda, S., Yamanaka, H., Ikushiro, S., Sakaki, T. and Yokoi, T.: Interactions between human UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A enzymes. J. Pharm. Sci., 99: 442-454 (2010).
18. Fujiwara, R., Nakajima, M., Yamanaka, H., Katoh, M. and Yokoi, T.: Interactions between human UGT1A1, UGT1A4, and UGT1A6 affect their enzymatic activities. Drug Metab. Dispos., 35: 1781-1787 (2007).
19. Fujiwara, R., Nakajima, M., Yamanaka, H., Nakamura, A., Katoh, M., Ikushiro, S., Sakaki, T. and Yokoi, T.: Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoforms. Drug Metab. Dispos., 35: 747-757 (2007).
20. Mori, Y., Kiyonaka, S. and Kanai, Y.: Transportsomes and channelsomes: are they functional units for physiological responses? Channels, 5: 387- 390 (2011).
21. Sumida, K., Kawana, M., Kouno, E., Itoh, T., Takano, S., Narawa, T., Tukey, R. H. and Fujiwara, R.: Importance of UDP-glucuronosyltransferase 1A1 expression in skin and its induction by UVB in neonatal hyperbilirubinemia. Mol. Pharmacol., 84: 679-686 (2013).
22. Fujiwara, R., Nguyen, N., Chen, S. and Tukey, R. H.: Developmental hyperbilirubinemia and CNS toxicity in mice humanized with the UDP glucuronosyltransferase 1 (UGT1) locus. Proc. Natl. Acad. Sci. USA, 107: 5024-5029 (2010).
23. Yamanaka, H., Yakabe, Y., Saito, K., Sekijima, M., Sato, H. and Shirai, T.: High-accuracy prediction of carcinogenicity by global quantitative analysis of post-translational modifications in a 28-day in vivo rat study. Cancer Genomics Proteomics, 5: 105-116 (2008).
24. Takeda, S., Ishii, Y., Iwanaga, M., Nurrochmad, A., Ito, Y., Mackenzie, P. I., Nagata, K., Yamazoe, Y., Oguri, K., et al.: Interaction of cytochrome P450 3A4 and UDP-glucuronosyltransferase 2B7: evidence for protein- protein association and possible involvement of CYP3A4 J-helix in the interaction. Mol. Pharmacol., 75: 956-964 (2009).
25. Fremont, J. J., Wang, R. W. and King, C. D.: Coimmunoprecipitation of UDP-glucuronosyltransferase isoforms and cytochrome P450 3A4. Mol. Pharmacol., 67: 260-262 (2005).
26. Taura, K., Yamada, H., Naito, E., Ariyoshi, N., Mori, M. and Oguri, K.: Activation of microsomal epoxide hydrolase by interaction with cytochromes P450: kinetic analysis of the association and substratespecific activation of epoxide hydrolase function. Arch. Biochem. Biophys., 402: 275-280 (2002).
27. Konopnicki, C. M., Dickmann, L. J., Tracy, J. M., Tukey, R. H., Wienkers, L. C. and Foti, R. S.: Evaluation of UGT protein interactions in human hepatocytes: effect of siRNA down regulation of UGT1A9 and UGT2B7 on propofol glucuronidation in human hepatocytes. Arch. Biochem. Biophys., 535: 143-149 (2013).
28. Kato, Y., Watanabe, C. and Tsuji, A.: Regulation of drug transporters by PDZ adaptor proteins and nuclear receptors. Eur. J. Pharm. Sci., 27: 487-500 (2006).
29. Mathias, R. A., Chen, Y. S., Kapp, E. A., Greening, D. W., Mathivanan, S. and Simpson, R. J.: Triton X-114 phase separation in the isolation and purification of mouse liver microsomal membrane proteins. Methods, 54: 396-406 (2011).